Gene · 384
Papers1,705
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,705
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis of Arginase Inhibitors: An Overview. | Pharmaceutics | 2025 | 39861764 | PubTator, text mining | PubMed |
| CD71+ erythroid cells promote multiple myeloma progression and impair anti-bacterial immune response. | Br J Haematol | 2025 | 39567409 | PubTator, text mining | PubMed |
| Linarin Identified as a Bioactive Compound of Lycii Cortex Ameliorates Insulin Resistance and Inflammation Through the c-FOS/ARG2 Signaling Axis. | Phytother Res | 2025 | 39523692 | PubTator, text mining | PubMed |
| Commensal myeloid crosstalk in neonatal skin regulates cutaneous type 17 inflammation. | bioRxiv | 2025 | 37873143 | PubTator, text mining | PubMed |
| Chromatin accessibility: biological functions, molecular mechanisms and therapeutic application. | Signal Transduct Target Ther | 2024 | 39627201 | PubTator, text mining | PubMed |
| Opportunities and Challenges of Arginase Inhibitors in Cancer: A Medicinal Chemistry Perspective. | J Med Chem | 2024 | 39558532 | PubTator, text mining | PubMed |
| Design and Synthesis of Acyclic Boronic Acid Arginase Inhibitors. | J Med Chem | 2024 | 39540340 | PubTator, text mining | PubMed |
| Immunometabolism: signaling pathways, homeostasis, and therapeutic targets. | MedComm (2020) | 2024 | 39492834 | PubTator, text mining | PubMed |
| Enhancing Drug Solubility, Bioavailability, and Targeted Therapeutic Applications through Magnetic Nanoparticles. | Molecules | 2024 | 39459222 | PubTator, text mining | PubMed |
| HNF4A-AS1 inhibits the progression of hepatocellular carcinoma by promoting the ubiquitin-modulated degradation of PCBP2 and suppressing the stability of ARG2 mRNA. | Int J Biol Sci | 2024 | 39430249 | PubTator, text mining | PubMed |
| Pathophysiology of Arginases in Cancer and Efforts in Their Pharmacological Inhibition. | Int J Mol Sci | 2024 | 39337272 | PubTator, text mining | PubMed |
| Lactate-upregulated ARG2 expression induces cellular senescence in fibroblast-like synoviocytes of osteoarthritis via activating the mTOR/S6K1 signaling pathway. | Int Immunopharmacol | 2024 | 39236462 | PubTator, text mining | PubMed |
| Connective Comprehension in Adults: The Influence of Lexical Transparency, Frequency, and Individual Differences. | Discourse Process | 2024 | 39193317 | PubTator, text mining | PubMed |
| Machine learning and experimental validation of novel biomarkers for hypertrophic cardiomyopathy and cancers. | J Cell Mol Med | 2024 | 39160643 | PubTator, text mining | PubMed |
| Hierarchical tricarboxylic acid cycle regulation by hepatocyte arginase 2 links the urea cycle to oxidative metabolism. | Cell Metab | 2024 | 39116884 | PubTator, text mining | PubMed |
| ARG2 knockdown promotes G0/G1 cell cycle arrest and mitochondrial dysfunction in adenomyosis via regulation NF-κB and Wnt/Β-catenin signaling cascades. | Int Immunopharmacol | 2024 | 39116499 | PubTator, text mining | PubMed |
| Prostaglandin D2 receptor 2 downstream signaling and modulation of type 2 innate lymphoid cells from patients with asthma. | PLoS One | 2024 | 39052598 | PubTator, text mining | PubMed |
| Towards genomic medicine: a tailored next-generation sequencing panel for hydroxyurea pharmacogenomics in Tanzania. | BMC Med Genomics | 2024 | 39026269 | PubTator, text mining | PubMed |
| Composition Characterization of Cinnamomum osmophloeum Kanehira Hydrosol and Its Enhanced Effects on Erectile Function. | Plants (Basel) | 2024 | 38891326 | PubTator, text mining | PubMed |
| Exploration of the Shared Gene Signatures and Molecular Mechanisms between Chronic Bronchitis and Antineutrophil Cytoplasmic Antibody-associated Glomerulonephritis: Evidence from Transcriptome Data. | Curr Pharm Des | 2024 | 38847168 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/384/papers?page=5